Danaher Corporation

NYSE:DHR Voorraadrapport

Marktkapitalisatie: US$168.4b

Danaher Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Danaher heeft een totaal eigen vermogen van $51.3B en een totale schuld van $17.5B, wat de schuld-eigenvermogensverhouding op 34.2% brengt. De totale activa en totale passiva bedragen respectievelijk $80.6B en $29.3B. De EBIT Danaher is $5.2B waardoor de rentedekking 63.4 is. Het heeft contanten en kortetermijnbeleggingen van $2.6B.

Belangrijke informatie

34.2%

Verhouding schuld/eigen vermogen

US$17.52b

Schuld

Rente dekkingsratio63.4x
ContantUS$2.63b
AandelenUS$51.31b
Totaal verplichtingenUS$29.31b
Totaal activaUS$80.62b

Recente financiële gezondheidsupdates

Recent updates

Understanding Danaher's Cautiousness

Oct 25

Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Sep 28
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Sep 25

Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Sep 12
Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Aug 28
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Danaher: Lofty Price, Bright Future

Aug 22

Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Aug 13
Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Danaher: Valuation Now Too High Even Compared To Own High Standards

Jul 16

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Jun 23
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Jun 05
Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Is Danaher (NYSE:DHR) A Risky Investment?

May 21
Is Danaher (NYSE:DHR) A Risky Investment?

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

May 01
It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Mar 11
Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12
Is Danaher (NYSE:DHR) Using Too Much Debt?

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher:  Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30
Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13
These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28
Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15
At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26
With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $10.1B ) DHR } overtreffen de korte termijn passiva ( $7.3B ).

Langlopende schulden: De kortetermijnactiva van DHR ( $10.1B ) dekken de langetermijnschulden ( $22.0B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 29% ) DHR wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van DHR is de afgelopen 5 jaar gedaald van 53.2% naar 34.2%.

Schuldendekking: De schuld van DHR wordt goed gedekt door de operationele kasstroom ( 35.9% ).

Rentedekking: De rentebetalingen op de schuld van DHR worden goed gedekt door EBIT ( 63.4 x dekking).


Balans


Ontdek gezonde bedrijven